RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions
- Application ID: EP13176714
- Status: █ GRANT OF PATENT INTENDED
This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). There is no patent agent firm in the market, which is specialized in this combination of IPC classes.